FDA Panel Backs mFlusiva mRNA Flu Shot for Elderly
Despite a number of significant limitations in the available safety and efficacy data for licensure review of Moderna, Inc.’s new mRNA influenza biologic mFlusiva, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee ((VRBPAC) voted on June 18, 2026 to recommend fast-tracked licensure of the first mRNA product to target […]
Hotez Calls for Police Deployment Against “Anti-Vaxxers”
Social media went a little bonkers last month when an interview with Texas Children’s Hospital’s Dr. Peter Hotez began circulating with the Big Pharma insider calling for the United Nations and NATO to deploy security forces against “anti-vaxxers” in the United States. Dr. Hotez’s statements first appeared on the YouTube channel of an international pediatric […]